UDP-Galactose (disodium)
UDP-Galactose disodium is a natural agonist of the P2Y14 receptor with an EC50 of 0.67 μM for the hP2Y14 receptor. UDP-Galactose disodium is a substrate for the transferase beta-1, 4 galactosyltransferase V (B4GALT5) . In addition, UDP-Galactose disodium is required for the biosynthesis of several abundant glycoconjugates that form the surface glycocalyx of Leishmania major[1][2][3].
Product Specifications
CAS Number
[137868-52-1]
UNSPSC
12352200
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite; P2Y Receptor
Type
Biochemical Assay Reagents
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Infection; Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/udp-galactose-disodium.html
Purity
99.73
Solubility
H2O : 250 mg/mL (ultrasonic)
Smiles
O=C(C=CN1[C@H]2[C@H](O)[C@H](O)[C@@H](COP(OP(O[C@@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)(O[Na])=O)(O[Na])=O)O2)NC1=O
Molecular Formula
C15H22N2Na2O17P2
Molecular Weight
610.27
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Isoform
P2Y14 Receptor
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items